Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Clinical Trial Services Expand Beyond Japan To Asia

This article was originally published in PharmAsia News

Executive Summary

Several companies have begun expanding Japanese services for clinical trials to other parts of Asia. Firms that already have committed to the expansion beyond Japan provide contract research to Japanese drug makers interested in lowering their costs by conducting trials in more than one country at a time. Among those expanding abroad are Itochu's Acronet, which has a partnership with Protech Pharmaservices of Taiwan, to obtain a presence in Singapore, Malaysia and elsewhere in Asia. Other Japanese firms abroad include EPS setting up a Hong Kong subsidiary and Cmic, already taking orders for services in Asia. (Click here for more - a subscription may be required



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts